FDA Warns Against Unregistered Postinor 2 with Pink Flower Packaging
•
•
•
•
•
•
•
FDA urged the public to be vigilant and prioritize their health by using only approved pharmaceutical products.
The Upper East Regional Office of the Food and Drugs Authority (FDA) has issued a warning about an unregistered version of Postinor 2, identifiable by a pink flower on its packaging. According to Mr. Abel Ndego, the FDA's Principal Regulatory Officer, while Postinor 2 is widely known for its use in preventing pregnancies, this specific version with the pink flower has not been approved by the FDA. As a result, the safety and effectiveness of this product cannot be guaranteed since it has not undergone the necessary regulatory scrutiny.
Mr. Ndego revealed that quality checks conducted on the product showed that its Active Pharmaceutical Ingredient (API) is below the required standard, reducing its ability to effectively prevent pregnancy. “Using this version will not provide the expected pharmaceutical outcome,” he cautioned during his address at the regional launch of the Goodlife Health Fair in Bolgatanga.
The three-day health fair was organized by the Upper East Regional Health Directorate in partnership with NORSAAC, a consortium partner under the USAID Accelerating Social and Behavior Change (ASBC) initiative. The event aimed to promote health and well being by encouraging positive behavioral change and increasing access to essential healthcare services. It was held under the theme, “Promoting good health through uptake of positive health behaviour.”
Mr. Ndego advised the public to purchase medicines only from licensed pharmacies and certified over the counter outlets. “This ensures that the products you buy are registered and properly stored to maintain their effectiveness,” he explained. He further emphasized the importance of correct storage, noting that improper storage can compromise the efficacy of medications. For instance, he highlighted that some medicines require refrigeration, adding that failure to store them under cool conditions can render them ineffective.
He expressed concern over the improper storage of children’s syrups, which are often kept on kitchen shelves instead of refrigerators. The warm temperatures in kitchens, he explained, can degrade the quality of such medicines, reducing their effectiveness and posing risks to children’s health.
At the fair, FDA officials displayed unregulated pharmaceutical products to raise public awareness about the dangers of using unauthorized medications. Mr. Ndego showcased a particular unregistered product featuring obscene images on its packaging, explaining that such items would never receive FDA approval. He warned against the growing trend of people purchasing products that claim to enhance male sexual performance, cautioning that such unregulated substances could have serious health implications.
Mr. Ndego urged the public to be vigilant and prioritize their health by using only approved pharmaceutical products, stressing the importance of following FDA guidelines to avoid the dangers posed by counterfeit or unregistered medicines.
blogpay
Total Comments: 0